Sanofi-Aventis receives allowance on reissuance application for Lovenox '618 patent.(Brief Article)

BIOTECH Patent News, December, 2004

Sanofi-Aventis (Paris, France) announced that a Notice of Allowance from the United States Patent and Trademark Office had been received on its subsidiary Aventis' application for reissuance of United States Patent 5,389,618 ('618 patent), relating to Lovenox. A Notice of Allowance constitutes a decision from the USPTO to allow a reissue application because the reissue patent application satisfies the statutory requirements of patentability. Based on the Notice of Allowance, Sanofi-Aventis currently believes that the patent could be reissued by the USPTO by about mid-year 2005.

Aventis filed an application with the USPTO in May 2003 seeking reissuance of the '618 patent. A reissuance application is typically used to seek modifications in the specifications...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement